News

Filter

26 to 35 of 478 results

ORCHID project aims to slash development time of tuberculosis drugs

ORCHID project aims to slash development time of tuberculosis drugs

14-01-2015

A collaborative project led by a scientist from UK pharma major GlaxoSmithKline has identified new compounds…

Antibiotics and Infectious diseasesGSKIsoniazidPharmaceuticalResearch

Roche, Meiji and Fedora team up to commercialize antibiotic OP0595

Roche, Meiji and Fedora team up to commercialize antibiotic OP0595

13-01-2015

Swiss pharma major Roche, Japanese pharma company Meiji Seika and private biotech company Fedora have…

Antibiotics and Infectious diseasesMeiji Seika PharmaOP0595PharmaceuticalResearchRoche

Harvoni scores another victory with inclusion on Prime’s preferred list

Harvoni scores another victory with inclusion on Prime’s preferred list

13-01-2015

US pharmacy Prime Therapeutics has agreed to provide hepatitis C drug Harvoni (ledipasvir/sofosbuvir)…

Antibiotics and Infectious diseasesBiotechnologyGileadHarvoniPricingUSA

Russia’s Nanolek commissions plant for production of nano-based drugs

12-01-2015

Russia's Nanolek has officially commissioned a new facility for the production of drugs for the treatment…

Antibiotics and Infectious diseasesCardio-vascularNanolekOncologyPharmaceuticalProductionRussia

SinSa Labs signs license agreement for technology platform leading to new antibiotics

SinSa Labs signs license agreement for technology platform leading to new antibiotics

09-01-2015

Singapore-based SinSa Labs has signed a license agreement with Singapore Health Services and technology…

Antibiotics and Infectious diseasesDorzidinLicensingPharmaceuticalResearchSingaporeSinSa Labs

Potential new MRSA-killing antibiotic developed by mining microbial 'dark matter'

Potential new MRSA-killing antibiotic developed by mining microbial 'dark matter'

08-01-2015

Researchers at Northeastern University in Boston, MA, and NovoBiotic Pharmaceuticals have made a breakthrough…

Antibiotics and Infectious diseasesMicrobiologyNovoBiotic PharmaceuticalsPharmaceuticalResearchTeixobactin

Cempra announces positive results from Phase III trial of solithromycin in bacterial pneumonia

Cempra announces positive results from Phase III trial of solithromycin in bacterial pneumonia

05-01-2015

Antibiotic specialist Cempra has announced positive top-line results from its pivotal Phase III trial…

Antibiotics and Infectious diseasesBiotechnologyCempraResearchsolithromycinUSA

BioCryst's Rapivab approved by FDA to treat influenza

BioCryst's Rapivab approved by FDA to treat influenza

23-12-2014

USA-based BioCryst Pharmaceuticals has received approval from the US Food and Drug Administration for…

Antibiotics and Infectious diseasesBioCryst PharmaceuticalsperamivirPharmaceuticalRegulationUSA

26 to 35 of 478 results

Back to top